[go: up one dir, main page]

ES476754A1 - Procedimiento para la preparacion de una composicion anti- biotica acuosa parenteral de color y ph estabilizados. - Google Patents

Procedimiento para la preparacion de una composicion anti- biotica acuosa parenteral de color y ph estabilizados.

Info

Publication number
ES476754A1
ES476754A1 ES476754A ES476754A ES476754A1 ES 476754 A1 ES476754 A1 ES 476754A1 ES 476754 A ES476754 A ES 476754A ES 476754 A ES476754 A ES 476754A ES 476754 A1 ES476754 A1 ES 476754A1
Authority
ES
Spain
Prior art keywords
preparation
stabilized aqueous
antibiotic compositions
aqueous parenteral
parenteral antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES476754A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD International Holdings GmbH
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of ES476754A1 publication Critical patent/ES476754A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Procedimiento para la preparación de una composición antibiótica parenteral estéril, de color y pH estabilizados, de una sal parenteralmente aceptable de un agente antibacteriano de aminoglicósido que tiene un anillo de piranosa que está insaturado entre las posiciones 4¿y 5'' y que contiene un substituyente de alminoalquilo en la posición 5'' ,caracterizado porque se calienta agua estéril destilada adecuada para aplicación parenteral y se disuelven en ella metilparabeno y/o propilparabeno en calidad de agentes de conservación, porque se enfría la solución así obtenida , tras lo cual se añaden cloruro de sodio y/o sulfato de sodio en calidad de electrolito y posiblemente EDTA disódico en calidad de agente quelante; y porque se añaden y disuelven fulfito y/o metabisulfito sódico en calidad de estabilizadores y la sal antibiótica seleccionada, con lo que la cantidad de sulfito sódico y/o metabisulfito sódico es tal que el pH de la composición resultante está comprendido entre 5,0 y 7,0
ES476754A 1978-01-16 1979-01-11 Procedimiento para la preparacion de una composicion anti- biotica acuosa parenteral de color y ph estabilizados. Expired ES476754A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/869,741 US4223022A (en) 1978-01-16 1978-01-16 Stabilized aminoglycoside antibiotic formulations

Publications (1)

Publication Number Publication Date
ES476754A1 true ES476754A1 (es) 1979-12-16

Family

ID=25354179

Family Applications (1)

Application Number Title Priority Date Filing Date
ES476754A Expired ES476754A1 (es) 1978-01-16 1979-01-11 Procedimiento para la preparacion de una composicion anti- biotica acuosa parenteral de color y ph estabilizados.

Country Status (24)

Country Link
US (1) US4223022A (es)
EP (1) EP0003150B1 (es)
JP (1) JPS5914447B2 (es)
AR (1) AR223967A1 (es)
AT (1) AT364715B (es)
AU (1) AU524288B2 (es)
BG (1) BG32561A3 (es)
CA (1) CA1129344A (es)
DD (1) DD141410A5 (es)
DE (1) DE2961370D1 (es)
DK (1) DK155306C (es)
ES (1) ES476754A1 (es)
FI (1) FI64287B (es)
GR (1) GR73655B (es)
IE (1) IE48254B1 (es)
IL (1) IL56409A (es)
MY (1) MY8500050A (es)
NO (1) NO153876C (es)
NZ (1) NZ189363A (es)
PH (1) PH18571A (es)
PL (1) PL119296B1 (es)
PT (1) PT69063A (es)
SU (1) SU976837A3 (es)
ZA (1) ZA7962B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327087A (en) * 1978-01-16 1982-04-27 Schering Corporation Stabilized Netilmicin formulations
HU197514B (en) * 1985-03-07 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for production of injection sulution containing acid-additional salts od sysomicin
US5977082A (en) * 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124317A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
DE3766984D1 (de) * 1986-03-07 1991-02-07 American Cyanamid Co Stabile injizierbare arzneiformulierung des 1,4-dihydroxy-5,8-bis((2-(hydroxyaethylamino)-aethyl)amino)anthrachinondihydrochlorids.
JPH05236765A (ja) * 1992-02-20 1993-09-10 Okuma Mach Works Ltd ローテータブル・リニア・アクチュエータ
JPH0630206U (ja) * 1992-09-14 1994-04-19 川崎重工業株式会社 締固め機械の安全ガード装置
US5912228A (en) * 1995-01-13 1999-06-15 Xoma Corporation Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products
US7794713B2 (en) 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4911403B1 (es) * 1970-12-29 1974-03-16
US3832286A (en) * 1971-02-03 1974-08-27 Schering Corp Sisomicin and methods for its production
US3995635A (en) * 1971-09-09 1976-12-07 Alza Corporation Ocular insert
US3956068A (en) 1972-07-14 1976-05-11 Schering Corporation Antibiotic G-52 and method for the production thereof
GB1405283A (en) 1972-08-17 1975-09-10 Scherico Ltd Antibiotics and processes for their preparation
US3880828A (en) 1973-02-23 1975-04-29 Schering Corp Antibiotics 66-40B and 66-40D from micromonospora inyoensis
US3962429A (en) 1973-08-01 1976-06-08 Chugai Seiyaku Kabushiki Kaisha Method for reducing side effects of aminoglycoside antibiotics and composition therefor
US3898330A (en) * 1973-08-01 1975-08-05 Squibb & Sons Inc Corticosteroid phosphate salts/neomycin sulfate ophthalmic
US3944064A (en) * 1973-10-26 1976-03-16 Alza Corporation Self-monitored device for releasing agent at functional rate
US4011390A (en) * 1974-02-15 1977-03-08 Schering-Plough Corporation Semi-synthetic aminocyclitol aminoglycoside antibiotics and methods for the preparation thereof
US4002742A (en) * 1974-03-19 1977-01-11 Schering Corporation 1-N-alkyl-4,6-di-(aminoglycosyl)-1,3-diaminocyclitols, methods for their manufacture, methods for their use as antibacterial agents, and compositions useful therefor
US4009328A (en) * 1975-05-02 1977-02-22 Schering Corporation Aminoglycoside 66-40C, method for its manufacture, method for its use as an intermediate in the preparation of known antibiotics and novel antibacterials
GB1529243A (en) * 1976-02-25 1978-10-18 Pfizer Ltd Process for the preparation of aminoglycoside derivatives and cyclic urethane intermediates for use therein

Also Published As

Publication number Publication date
IE790045L (en) 1979-07-16
NO153876C (no) 1989-08-22
FI64287B (fi) 1983-07-29
PL119296B1 (en) 1981-12-31
NO790085L (no) 1979-07-17
BG32561A3 (bg) 1982-08-16
NO153876B (no) 1986-03-03
CA1129344A (en) 1982-08-10
AU524288B2 (en) 1982-09-09
ZA7962B (en) 1979-12-27
GR73655B (es) 1984-03-27
DE2961370D1 (en) 1982-01-28
JPS54100346A (en) 1979-08-08
IE48254B1 (en) 1984-11-14
AU4332079A (en) 1979-07-26
DK155306C (da) 1989-08-28
EP0003150B1 (en) 1981-11-25
AR223967A1 (es) 1981-10-15
SU976837A3 (ru) 1982-11-23
MY8500050A (en) 1985-12-31
JPS5914447B2 (ja) 1984-04-04
IL56409A0 (en) 1979-03-12
PT69063A (en) 1979-02-01
DK155306B (da) 1989-03-28
IL56409A (en) 1981-09-13
EP0003150A1 (en) 1979-07-25
NZ189363A (en) 1984-07-06
DK14579A (da) 1979-07-17
DD141410A5 (de) 1980-04-30
PL212809A1 (es) 1980-02-11
AT364715B (de) 1981-11-10
US4223022A (en) 1980-09-16
ATA20479A (de) 1981-04-15
FI790086A (fi) 1979-07-17
PH18571A (en) 1985-08-12

Similar Documents

Publication Publication Date Title
GB1438312A (en) N-substituted chloroacetanilide for regulating plant growth
MY102919A (en) Pleuromutilin derivatives process for their preparation and their use.
ES476754A1 (es) Procedimiento para la preparacion de una composicion anti- biotica acuosa parenteral de color y ph estabilizados.
GB1503680A (en) Pharmaceutical preparations having psychotropic activity and process for their manufacture
MY101614A (en) Improvements in or relating to benzothiophene derivatives as antiasthmatic agents
GB1493998A (en) Propanolamine derivatives
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
GB1462560A (en) Crop protection composition and method of application whereby the drift of spraying liquids may be reduced
GB1533906A (en) Process for reducing the water sensitivity of polyvinyl alcohol
GB1235599A (en) Lincomycin phosphate derivatives and pharmaceutical compositions containing them
PT78991A (en) Process for preparing a novel antibiotic and of compositions containing the same
GB1416292A (en) X-ray contrast agents their application and a process for their production
ES484321A1 (es) Un procedimiento para la preparacion de un compuesto de 3- carbamoiloximetil-cefalosporina
GB1433916A (en) Thiophosphoric acid amides as nematocides insecticides and acaricides
ES467886A1 (es) Procedimiento para la preparacion de derivados de acido oleanoico.
AU534886B2 (en) Solutions of canrenoic acid and furosemide salts
GB1392007A (en) Cycloalkylthiazoles
GB1139813A (en) New surface active agents, and their preparation and uses
GB1291687A (en) A method for the production of formylnitrile derivatives
ES8306758A1 (es) Un procedimiento para la preparacion de un derivado de beta-lactama.
GB1388460A (en) N-demethyl-celesticetin derivatives
IL74353A (en) Antibiotic cp-63517,an acidic polycyclic ether(ionophore)antibiotic,its preparation and animal feed compositions containing it
GB1467919A (en) Polycyclic ether antibiotic
GB1360553A (en) Chemical compounds suitable for use as x-ray contrast agents
GB1430179A (en) Derivatives of hydroxy sulphonic acids and their use in dyeing and printing fibrous cellulosic materials